Virtus ETF Advisers’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,404
| Closed | -$43.9K | – | 462 |
|
|
2023
Q1 | $43.9K | Sell |
1,404
-539
| -28% | -$16.9K | 0.02% | 433 |
|
|
2022
Q4 | $137K | Sell |
1,943
-271
| -12% | -$19.1K | 0.07% | 374 |
|
|
2022
Q3 | $191K | Buy |
2,214
+17
| +0.8% | +$1.47K | 0.08% | 324 |
|
|
2022
Q2 | $182K | Buy |
2,197
+943
| +75% | +$78.1K | 0.07% | 313 |
|
|
2022
Q1 | $208K | Sell |
1,254
-75
| -6% | -$12.4K | 0.09% | 196 |
|
|
2021
Q4 | $222K | Buy |
+1,329
| New | +$222K | 0.08% | 195 |
|
|
2021
Q2 | – | Sell |
-5,431
| Closed | -$324K | – | 401 |
|
|
2021
Q1 | $324K | Buy |
5,431
+96
| +2% | +$5.73K | 0.14% | 225 |
|
|
2020
Q4 | $278K | Sell |
5,335
-1,034
| -16% | -$53.9K | 0.12% | 251 |
|
|
2020
Q3 | $308K | Sell |
6,369
-869
| -12% | -$42K | 0.16% | 215 |
|
|
2020
Q2 | $375K | Buy |
+7,238
| New | +$375K | 0.18% | 225 |
|